Group One Trading, L.P. Kiniksa Pharmaceuticals, Ltd. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.63 - $21.74 $38,345 - $47,284	2,175 New	2,175 $42,000
Q2 2022 Aug 11, 2022	SELL	$7.6 - $11.41 $33,645 - $50,512	-4,427 Reduced 77.63%	1,276 $12,000
Q1 2022 May 12, 2022	SELL	$9.3 - $12.37 $36,335 - $48,329	-3,907 Reduced 40.66%	5,703 $57,000
Q4 2021 Feb 11, 2022	SELL	$10.39 - $15.15 $184,516 - $269,048	-17,759 Reduced 64.89%	9,610 $113,000
Q3 2021 Nov 12, 2021	BUY	$11.39 - $16.23 $147,466 - $210,129	12,947 Added 89.77%	27,369 $312,000
Q2 2021 Aug 10, 2021	BUY	$13.22 - $19.09 $127,480 - $184,084	9,643 Added 201.78%	14,422 $201,000
Q1 2021 May 12, 2021	BUY	$16.68 - $23.97 $79,713 - $114,552	4,779 New	4,779 $88,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $690M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.